BNP PARIBAS FINANCIAL MARKETS - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 61 filers reported holding SUTRO BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$114,857
-7.2%
33,100
+24.3%
0.00%
Q2 2023$123,778
-74.3%
26,619
-74.5%
0.00%
-100.0%
Q1 2023$482,074
+85.5%
104,345
+224.4%
0.00%
Q4 2022$259,861
-99.9%
32,161
-19.9%
0.00%
Q3 2022$222,838,000
+25.9%
40,151
+18.2%
0.00%
Q2 2022$176,932,000
-18.7%
33,960
+28.3%
0.00%
Q1 2022$217,624,000
-14.0%
26,475
+55.6%
0.00%
Q4 2021$253,124,000
+27.4%
17,011
+61.8%
0.00%
Q3 2021$198,609,000
+136.8%
10,514
+133.0%
0.00%
Q2 2021$83,878,000
-86.9%
4,512
-83.9%
0.00%
-100.0%
Q1 2021$638,509,000
+378.8%
28,054
+356.8%
0.00%
Q4 2020$133,343,000
+114.5%
6,142
-0.7%
0.00%
Q3 2020$62,179,000
+866.6%
6,187
+646.3%
0.00%
Q2 2020$6,433,000
-81.4%
829
-75.5%
0.00%
Q1 2020$34,496,000
+29.2%
3,382
+39.3%
0.00%
Q4 2019$26,708,000
+131.2%
2,428
+91.0%
0.00%
Q3 2019$11,553,000
-14.0%
1,271
+7.6%
0.00%
Q2 2019$13,440,000
-22.2%
1,181
-22.1%
0.00%
Q1 2019$17,267,0001,5160.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$33,918,00014.78%
Samsara BioCapital, LLC 1,675,579$31,149,0003.84%
First Light Asset Management, LLC 2,072,875$38,535,0002.31%
AJU IB Investment Co., Ltd. 175,000$3,253,0001.88%
FRAZIER MANAGEMENT LLC 1,001,421$18,616,0001.72%
Opaleye Management Inc. 496,900$9,237,0001.53%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,331$2,590,0000.68%
Parkman Healthcare Partners LLC 163,389$3,037,0000.66%
Eventide Asset Management 2,370,975$44,076,0000.59%
BVF INC/IL 826,825$15,371,0000.58%
View complete list of SUTRO BIOPHARMA INC shareholders